We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current Z1BH34 market cap is 30.89B. The company's latest EPS is USD 4.9000 and P/E is 22.36.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.75B | 1.94B | 1.89B | 1.94B | 1.82B |
| Operating Income | 266.6M | 354.3M | 265.9M | 351.3M | 279.6M |
| Net Income | 162.7M | 419.2M | 172.4M | 242.8M | 249.1M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 7.98B | 7.02B | 7.84B | 6.94B | 7.39B |
| Operating Income | 1.14B | -87.8M | 780.1M | 696.3M | 1.28B |
| Net Income | 1.13B | -138.9M | 401.6M | 231.4M | 1.02B |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 21.22B | 21.5B | 21.45B | 21.52B | 21.72B |
| Total Liabilities | 8.7B | 9.01B | 8.85B | 8.77B | 9.34B |
| Total Equity | 12.52B | 12.49B | 12.61B | 12.75B | 12.38B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 24.64B | 24.42B | 23.46B | 21.07B | 21.5B |
| Total Liabilities | 12.25B | 12.22B | 10.79B | 9.04B | 9.01B |
| Total Equity | 12.39B | 12.2B | 12.67B | 12.03B | 12.49B |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 993.2M | 1.58B | 228M | 597.4M | 993.2M |
| Investing | -558.2M | -778.9M | -195M | -442M | -597M |
| Financing | -512.1M | -763.5M | -50.1M | -142.1M | -243.9M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 1.59B | 1.2B | 1.5B | 1.28B | 1.58B |
| Investing | -729.3M | -613.8M | -503.6M | -529.2M | -778.9M |
| Financing | -779.9M | -421.8M | -1.31B | -843.8M | -763.5M |
| Market Cap | 30.89B |
| Price to Earnings Ratio | 22.36 |
| Price to Sales Ratio | 3.1 |
| Price to Cash Ratio | 55.06 |
| Price to Book Ratio | 1.83 |
| Dividend Yield | 0.70% |
| Shares Outstanding | 208.98M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | -2.23% |
| 52 Week High | 158.25 |
| 52 Week Low | 146.40 |
| Spread (Intraday) | 1.7 (1.02%) |
| Company Name | Zimmer Biomet Holdings Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.zimmerbiomet.com |
| Industry | ortho,prosth,surg appl,suply (3842) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
